Exchange: OTC·Updated 10:48 AM EDT

RBSHInspyr Therapeutics Inc

$0.00
$0.00
(0.00%)
Today
Mkt Cap$3,213.00
Vol50,000.00

About

Rebus Holdings, Inc. is a pharmaceutical company engaged in the research and development of novel therapeutics for the treatment of cancer. Its product pipeline includes Mipsagargin, a dual A2A/A2B antagonist, an A2A antagonist, an A2B antagonist, and an A2A agonist. The company was founded by Craig A. Dionne, John T. Issacs, and Samuel R. Denmeade on November 21, 2003 and is headquartered in Westlake Village, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Rebus Holdings Inc?
What is the 52-week high for Rebus Holdings Inc?
What was Rebus Holdings Inc stock price yesterday?
What is the 50-day moving average of Rebus Holdings Inc?

Advertisement|Remove ads.